The stock's fall snapped a three-day winning streak.

AbbVie lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses ...

BofA Securities has recently resumed AbbVie Inc (ABBV) stock to Neutral rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 5, 2024, Daiwa Securities had reduced the ...

Boltwood Capital Management decreased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.4% in the 4th quarter, ...

CWA Asset Management Group LLC cut its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 13.1% in the 4th quarter, ...

Here are 25 top dividend stocks to buy and hold in 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.

Medtronic has been raising its dividend for 47 consecutive years and it offers a high yield now. Bristol Myers Squibb offers ...

Abbvie Inc., Novartis, AstraZeneca and the Pharmaceutical Research and Manufacturers of America filed a legal challenge last ...

Shares of AbbVie Inc. ABBV inched 0.99% higher to $181.22 Friday, on what proved to be an all-around favorable trading ...

AbbVie Inc (ABBV) stock saw a modest uptick, ending the day at $179.44 which represents a slight increase of $1.74 or 0.98% from the prior close of $177.7. The stock opened at $178.66 and touched a ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), Palvella ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...